:: Library Catalog

Ata uhi

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Kaituhi matua:	Snehal Kanase1*, Kartiki Dome2, Shivtej Kanase3, Dr. Kiran Kotade4, Sangita Bhandare5
Hōputu:	Recurso digital
Reo:
I whakaputaina:	Zenodo 2026
Ngā marau:	Anxiety disorders, Gut-brain axis, Gut microbiota, Neuroinflammation, Oxidative stress, Anxiolytic activity, Neurotransmitter
Urunga tuihono:	https://doi.org/10.5281/zenodo.20133634
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Human gut microbiota - A lifetime history: from birth to adulthood (Riviera Maya, Mexico - June 26th, 2015)
mā: Luis Bustos Fernández
I whakaputaina: (2016)

EVALUATION OF ANTI-ANXIETY ACTIVITY OF Sechium edule LEAF EXTRACT ON EXPERIMENTAL ANIMALS
mā: Ananya M. N., me ētahi atu.
I whakaputaina: (2025)

Gut Microbiota: characterization in some patients with active digestive disorders
mā: Ileana Martínez-Cabrera
I whakaputaina: (2019)

Alterations of gut bacteria Akkermansia muciniphila and Faecalibacterium prausnitzii in late post-transplant period after liver transplantation
mā: Alexander Kukov
I whakaputaina: (2022)

ASD-like behaviors, a dysregulated inflammatory response and decreased expression of PLP1 characterize mice deficient for sialyltransferase ST3GAL5
mā: Strekalova, Tatyana, me ētahi atu.
I whakaputaina: (2021)

Medicinal Plants and Herbal Medicines for Managing Anxiety and Depression via Gut Microbiota Modulation
mā: Priscilla Magro Reque, me ētahi atu.
I whakaputaina: (2025)

Computational Insights Into Plant‐Derived Compounds Modulating the Microbiota–Gut–Brain Axis in Neuroinflammatory Diseases
mā: Amin Purhematy, me ētahi atu.
I whakaputaina: (2026)

Issue Information
I whakaputaina: (2025)

The Burden of Pancreatic Cancer From Asia in 2022 and Predictions to 2050 According to GLOBOCAN Estimates
mā: Lin‐Kang Zhao, me ētahi atu.
I whakaputaina: (2025)

Adult Idiopathic Hypertrophic Pyloric Stenosis
mā: Yunpeng Shao, me ētahi atu.
I whakaputaina: (2026)

Analysis of Global Inequalities in Inflammatory Bowel Disease
mā: Baoyan Chen, me ētahi atu.
I whakaputaina: (2025)

A Message From the Editors‐in‐Chief: Advancing Integration and Innovation in Gut Medicine
mā: Bin Cong, me ētahi atu.
I whakaputaina: (2025)

Issue Information
I whakaputaina: (2026)

Progress on the Protective Effect and the Mechanism of Chinese Medicine Injection and Chinese Medicine Monomeric Small Molecules on Sepsis‐Related Liver Injury
mā: Xiang Yunsheng, me ētahi atu.
I whakaputaina: (2026)

Forging a New Integrative Pathway in Digestive Health: The Launch of Gut Medicine
mā: Wei Wei
I whakaputaina: (2025)

Dynamic Randomization With Drug Traceability Code: Innovative Approach to Address Randomization and Drug Management Challenges in Cellular Therapy Clinical Trials
mā: Xue‐lu Zhu, me ētahi atu.
I whakaputaina: (2025)

Chinese Patent Medicine Ameliorate Ulcerative Colitis in Mice by Restoring the Th17/Treg Balance
mā: Tao Zhang, me ētahi atu.
I whakaputaina: (2025)

Hepcidin–Ferroportin Axis, Gut Microbiota, and Ferroptosis Across Chronic Liver Diseases: Mechanistic Integration of an Iron Dysregulation Triad
mā: Debabrata Dash, me ētahi atu.
I whakaputaina: (2026)

Anti-Anxiety Agents from Natural and Synthetic Origin
mā: Varad Sonawane *, Suvarna Katti
I whakaputaina: (2025)

Gut Contents Study of White Leg (Litopenaeus vannamei) Shrimp during a Culture Period from Earthen Ponds in Delvar of Bushehr
mā: Farhadian, O., me ētahi atu.
I whakaputaina: (2015)

Gut Microbiota and Gastric Cancer: The Immunoregulatory Mechanism and the Preventive Role of Microbiota‐Derived Short‐Chain Fatty Acids
mā: Anusree Chakraborty, me ētahi atu.
I whakaputaina: (2025)

Emerging Noninvasive Biomolecular Checkpoints for Healthy Microbiomes
mā: A. Dahl, me ētahi atu.
I whakaputaina: (2025)

Probiotic Intervention in the Management of Urolithiasis: A Pathway to Gut Microbiome Modulation
mā: Roopa Shri Balakrishnan, me ētahi atu.
I whakaputaina: (2026)

Distinguishing Crohn’s Disease From Non–Crohn’s Ileitis: A Gut Microbiome–Based Approach
mā: Nalini Raghunathan, me ētahi atu.
I whakaputaina: (2025)

Assessment of Ameliorative Effect of Myrica esculenta in a DSS-Induced Murine Model against Ulcerative Colitis
mā: Monika Joshi, me ētahi atu.
I whakaputaina: (2024)

Bacterial Cell Lysates of Bacillus sp. F Isolated From Permafrost Diminish DNA Damage by Hydrogen Peroxide in Murine Blood Cells Ex Vivo
mā: A. V. Brouchkov, me ētahi atu.
I whakaputaina: (2024)

The Stool and Oral Microbiome of Rheumatoid Arthritis Patients Taking Disease‐Modifying Antirheumatic Drugs
mā: Lara Bereza-Malcolm, me ētahi atu.
I whakaputaina: (2025)

Lactobacillus plantarum in the Gut of a Marine Fish from a Caloocan Local Market
mā: Nieves L. Capili, me ētahi atu.
I whakaputaina: (2024)

Assessment of the Bacterial Content of Commercially Available Probiotic Products Containing Lactic Acid Bacteria and Their Probiotic Potentials in Jos
mā: Florence Yachim Danjuma, me ētahi atu.
I whakaputaina: (2025)

Investigating Dysbiosis‐Driven Colonization by Staphylococcus aureus and the Mitigative Potential of Medicinal Plants in Diabetes‐Linked Inflammation
mā: Kehinde Abel Ajadi, me ētahi atu.
I whakaputaina: (2026)

Gut Microbiome: An Intersection between Human Genome, Diet, and Epigenetics
mā: Abdullahi Y. Muhammad, me ētahi atu.
I whakaputaina: (2024)

Metabolic Profiling and Early Diagnosis of Alcoholic Fatty Liver Disease Using Support Vector Machine Model
mā: Minjie You, me ētahi atu.
I whakaputaina: (2024)

The Role of Gut Microbiota in Modulating Cancer Therapy Efficacy
mā: Mostafa A. Madkour, me ētahi atu.
I whakaputaina: (2024)

Gut Microbiome Variability in Pediatric Patients With Inflammatory Bowel Disease
mā: Katerina Maeder, me ētahi atu.
I whakaputaina: (2025)

Diarrheagenic and Uropathogenic Escherichia coli : Biofilm Production and Virulence Factors in Clinical Isolates From Argentina
mā: Nora B. Molina, me ētahi atu.
I whakaputaina: (2025)

Exploring the Link Between the Gut Mycobiome and Neurological Disorders
mā: Ali Yetgin
I whakaputaina: (2024)

Probiotic Potential and Modulatory Effects of Mixed Culture of Lactic Acid Bacteria on Mice Infected With Escherichia coli O157:H7
mā: Adaeze Ngozi Ibejekwe, me ētahi atu.
I whakaputaina: (2025)

Probiotics in Disease Management for Sustainable Poultry Production
mā: Gelana Urgesa Ayana, me ētahi atu.
I whakaputaina: (2024)

Effects of Resistant Starch Supplementation on Metabolic Parameters and Oxidative Stress in C57BL/6 Mice Fed With a High‐Fat Diet
mā: Héric Holland, me ētahi atu.
I whakaputaina: (2024)

Gut–Oral Microbial Dysbiosis: A Correlated Ecosystem
mā: Zeba Rahman Siddiqui, me ētahi atu.
I whakaputaina: (2025)